REQUEST A DEMO
Total
USD $0.00
Search more companies

Vorwarts Pharma SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Vorwarts Pharma SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Vorwarts Pharma SIA is a company based in Latvia, with its head office in Riga. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on February 26, 2019. The total number of employees is currently 5 (2023). In its most recent financial highlights, the company reported a net sales revenue increase of 17.17% in 2024. There was a total growth of 26.81% in Vorwarts Pharma SIA’s total assets over the same period. The net profit margin of Vorwarts Pharma SIA increased by 3.33% in 2024.

Headquarters
Krisjana Barona iela 15
Riga; Riga; Postal Code: 1011

Contact Details: Purchase the Vorwarts Pharma SIA report to view the information.

Basic Information
Total Employees:
Purchase the Vorwarts Pharma SIA report to view the information.
Registered Capital:
Purchase the Vorwarts Pharma SIA report to view the information.
Financial Auditors:
Purchase the Vorwarts Pharma SIA report to view the information.
Incorporation Date:
February 26, 2019
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Vorwarts Pharma Llc (Ukraine)
Company Performance
Financial values in the chart are available after Vorwarts Pharma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
17.17%
Total operating revenue
17.17%
Operating profit (EBIT)
25.13%
EBITDA
25.13%
Net Profit (Loss) for the Period
26.24%
Total Assets
26.81%
Total Equity
36.69%
Operating Profit Margin (ROS)
2.91%
Net Profit Margin
3.33%
Return on Equity (ROE)
-2.22%
Quick Ratio
7.53%
Cash Ratio
1.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?